Matches in Wikidata for { <http://www.wikidata.org/entity/Q47680099> ?p ?o ?g. }
- Q47680099 description "2016 nî lūn-bûn" @default.
- Q47680099 description "2016年の論文" @default.
- Q47680099 description "2016年学术文章" @default.
- Q47680099 description "2016年学术文章" @default.
- Q47680099 description "2016年学术文章" @default.
- Q47680099 description "2016年学术文章" @default.
- Q47680099 description "2016年学术文章" @default.
- Q47680099 description "2016年學術文章" @default.
- Q47680099 description "2016年學術文章" @default.
- Q47680099 description "2016年學術文章" @default.
- Q47680099 description "2016年學術文章" @default.
- Q47680099 description "2016年學術文章" @default.
- Q47680099 description "2016年學術文章" @default.
- Q47680099 description "2016년 논문" @default.
- Q47680099 description "article científic" @default.
- Q47680099 description "article scientific" @default.
- Q47680099 description "article scientifique (publié 2016)" @default.
- Q47680099 description "articol științific" @default.
- Q47680099 description "articolo scientifico" @default.
- Q47680099 description "artigo científico (publicado na 2016)" @default.
- Q47680099 description "artigo científico (publicado na 2016)" @default.
- Q47680099 description "artigo científico" @default.
- Q47680099 description "artikull shkencor" @default.
- Q47680099 description "artikulong pang-agham" @default.
- Q47680099 description "artykuł naukowy" @default.
- Q47680099 description "artículo científico publicado en 2016" @default.
- Q47680099 description "artículu científicu" @default.
- Q47680099 description "bilimsel makale" @default.
- Q47680099 description "bài báo khoa học" @default.
- Q47680099 description "mokslinis straipsnis" @default.
- Q47680099 description "naučni članak" @default.
- Q47680099 description "scienca artikolo" @default.
- Q47680099 description "scientific article" @default.
- Q47680099 description "teaduslik artikkel" @default.
- Q47680099 description "tieteellinen artikkeli" @default.
- Q47680099 description "tudományos cikk" @default.
- Q47680099 description "vedecký článok" @default.
- Q47680099 description "vetenskaplig artikel" @default.
- Q47680099 description "videnskabelig artikel (udgivet 2016)" @default.
- Q47680099 description "vitenskapelig artikkel" @default.
- Q47680099 description "vitskapeleg artikkel" @default.
- Q47680099 description "vědecký článek" @default.
- Q47680099 description "wetenschappelijk artikel" @default.
- Q47680099 description "wissenschaftlicher Artikel" @default.
- Q47680099 description "επιστημονικό άρθρο" @default.
- Q47680099 description "мақолаи илмӣ" @default.
- Q47680099 description "мақолаи илмӣ" @default.
- Q47680099 description "наукова стаття, опублікована в серпні 2016" @default.
- Q47680099 description "научна статия" @default.
- Q47680099 description "научная статья" @default.
- Q47680099 description "научни чланак" @default.
- Q47680099 description "научни чланак" @default.
- Q47680099 description "գիտական հոդված" @default.
- Q47680099 description "מאמר מדעי" @default.
- Q47680099 description "سائنسی مضمون" @default.
- Q47680099 description "مقالة علمية" @default.
- Q47680099 description "مقالهٔ علمی" @default.
- Q47680099 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q47680099 description "บทความทางวิทยาศาสตร์" @default.
- Q47680099 description "სამეცნიერო სტატია" @default.
- Q47680099 name "Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial." @default.
- Q47680099 name "Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial." @default.
- Q47680099 type Item @default.
- Q47680099 label "Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial." @default.
- Q47680099 label "Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial." @default.
- Q47680099 prefLabel "Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial." @default.
- Q47680099 prefLabel "Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial." @default.
- Q47680099 P1433 Q47680099-6ACA7155-A10F-4C5D-844A-27383D17A760 @default.
- Q47680099 P1476 Q47680099-9F3CB31F-8384-436F-9A8B-B466C52F4C25 @default.
- Q47680099 P2093 Q47680099-0CBEFE4A-E0C5-4493-999D-459FA60DC45E @default.
- Q47680099 P2093 Q47680099-173D33AC-06F2-4814-A136-8D6FCD989340 @default.
- Q47680099 P2093 Q47680099-312F52E1-D12C-4279-8A31-4D4D667817C3 @default.
- Q47680099 P2093 Q47680099-5FA546F5-D5E9-4E14-B8DA-71A35EB7DAC7 @default.
- Q47680099 P2093 Q47680099-66CA9C00-FC0B-4D20-8F7B-601D976C7F4F @default.
- Q47680099 P2093 Q47680099-689DC104-C052-47FE-B179-A8AC00DBE06B @default.
- Q47680099 P2093 Q47680099-6DD1BD6E-0DBC-4D4C-A29B-270FFD987E61 @default.
- Q47680099 P2093 Q47680099-70CA5F1E-47C8-4A47-88AC-ACF0F73883E7 @default.
- Q47680099 P2093 Q47680099-7CCD436E-4D97-43DD-87DC-DD6BC4CF947F @default.
- Q47680099 P2093 Q47680099-8CDB3FA8-7A6C-47D8-BB19-167485288126 @default.
- Q47680099 P2093 Q47680099-992DE953-A871-4F41-800F-0AE5C5E0D6C5 @default.
- Q47680099 P2093 Q47680099-9C4285C6-13F3-4D34-8353-D91B7C63CAED @default.
- Q47680099 P2093 Q47680099-B6EF62F1-77F0-44E6-AEDD-C29F9F9B14F2 @default.
- Q47680099 P2093 Q47680099-BA24B2D5-B19F-4542-9672-9663B365B940 @default.
- Q47680099 P2093 Q47680099-C51C9232-CF60-41D4-AF6B-B1DBCA528886 @default.
- Q47680099 P2093 Q47680099-DD37A5B8-B733-42A5-9A88-A24272E2925B @default.
- Q47680099 P2093 Q47680099-F1BF544D-EC01-4B5A-BD0C-4252B08E2409 @default.
- Q47680099 P2093 Q47680099-FC256EB3-C6E7-48F7-BB53-5F7A63064300 @default.
- Q47680099 P2860 Q47680099-024B3D98-DDE5-45BC-BD16-127E30F332A9 @default.
- Q47680099 P2860 Q47680099-03F6C698-B823-46A8-B3AD-68308FAA0FCF @default.
- Q47680099 P2860 Q47680099-12176881-8899-4456-8A82-1B78CF245033 @default.
- Q47680099 P2860 Q47680099-125CCC93-ECD2-49F9-BD97-03D559B79934 @default.
- Q47680099 P2860 Q47680099-2B86CBD1-CA95-418D-A0C5-C3E55390C530 @default.
- Q47680099 P2860 Q47680099-3F1DBDB4-317B-499D-B71D-3A7C955D696D @default.
- Q47680099 P2860 Q47680099-4B64D5D8-9929-4160-AACF-5D7EA44E7467 @default.
- Q47680099 P2860 Q47680099-4C87EA32-25A3-4C0F-82A3-A8B034DCA5CA @default.
- Q47680099 P2860 Q47680099-5A5BA609-AF38-4D1C-A615-02339425EDBE @default.
- Q47680099 P2860 Q47680099-88521137-E2A4-40B9-8512-D860F6434166 @default.
- Q47680099 P2860 Q47680099-8C646229-8A8C-41F9-9BA3-DB448600886B @default.
- Q47680099 P2860 Q47680099-AB12279C-870E-47F2-8EDE-158C0E35058E @default.
- Q47680099 P2860 Q47680099-D2191E41-B67F-4491-9549-2CA45CE47C45 @default.